Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noor Diab

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The FEBS Journal|January 20, 2021
Transposable element regulation and expression in cancerErin E Grundy, Noor Diab, Katherine B Chiappinelli
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|May 30, 2023
Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element LociTomas Kanholm, Uzma Rentia, Melissa Hadley, et al.
Cancer Research|August 26, 2021
Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a <i>TP53</i>-Dependent MannerJames I McDonald, Noor Diab, Elisa Arthofer, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Cancer Discovery|January 8, 2025
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune EvasionCharles A Ishak, Sajid A Marhon, Naïri Tchrakian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The FEBS Journal|January 20, 2021
Transposable element regulation and expression in cancerErin E Grundy, Noor Diab, Katherine B Chiappinelli
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|May 30, 2023
Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element LociTomas Kanholm, Uzma Rentia, Melissa Hadley, et al.
Cancer Research|August 26, 2021
Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a <i>TP53</i>-Dependent MannerJames I McDonald, Noor Diab, Elisa Arthofer, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Cancer Discovery|January 8, 2025
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune EvasionCharles A Ishak, Sajid A Marhon, Naïri Tchrakian, et al.
Pageof 1